DreaMed brings personalization to diabetes treatment

Headshot Eran Atlas 1

In healthcare, personalization is key. What works for one person may not work for another. And while this can be said for all diseases and conditions, it is especially true for diabetes. 

Healthcare providers have come to learn that the one-size-fits-all approach in diabetes treatment often results in suboptimal results—and even prolonged complications. Diabetes care requires the acute management of blood sugar levels, measured by glycated hemoglobin in the blood. Most people with diabetes have a glycemic goal of 7 percent or less. There are two primary reasons why patients fail to meet their target glycemic levels: the patient’s inability to adhere to their treatment plan and a phenomenon known as therapeutic inertia. 

Therapeutic inertia is defined as “the failure to initiate or intensify therapy in a timely manner according to evidence-based clinical guidelines.” Currently, it can take up to seven years to adjust a patient’s treatment plan, often resulting in gaps in therapy. For a progressive, chronic disease such as diabetes, this can be incredibly detrimental for patients. 

DreaMed Diabetes, the first and only company to receive FDA clearance for its support system, utilizes artificial intelligence and machine learning to provide accurate and successful diabetes treatment. DreaMed’s Advisor Pro, for example, is a simple, user-friendly decision-support system for healthcare professionals that quickly analyzes and recommends optimal treatment plans to patients. 

Therapeutic inertia’s uniquely evasive nature lies in its many causes. The phenomenon can be caused by the patient, the physician, or both. A lack of time, resources, or data often result in health care providers inappropriately assessing patient needs, such as over or under estimating patient care. 

Failed diabetes treatments are not caused by a lack of drugs or tools, rather, they are caused by the lack of knowledge on when to use them—and on who. Diabetes patients are often treated similarly despite having varying underlying conditions that may significantly alter treatment efficacy. The overwhelming prevalence of therapeutic inertia (it affects up to 50 percent of those with type 2 diabetes) only highlights the need for personalized care. 

Screen Shot 2022 05 19 at 9.05.20 AM

While personalized treatments have proven to be more effective, they require timely and accurate monitoring of the nuanced changes in patient symptoms and overall condition. Today, DreaMed’s technology enables patients and healthcare providers to do exactly that.

Every person with diabetes has a different level of cardiovascular health, weight, and lifestyle—as well as the ways symptoms present themselves. All types and stages of diabetes require individualized care—without which, physicians are merely guessing, hoping for the best.

DreaMed leverages AI to take the burden off both physicians and patients using its endo.digital product. Every endo.digital recommendation is backed by ample patient data, collected from different diabetes devices like continuous glucose monitoring device, a self monitoring glucose device, or an insulin pump. With the aid of such technology, adjusting a patient’s treatment plan can go from seven years merely seconds.

Unfortunately, therapeutic inertia is not the only concern. Issues surrounding inaccessibility, lack of resources, challenges in lifestyle modification, and inadequate diabetes education are very common among patients and providers. 

Truly personalized healthcare comes from strengthening two sides: that of the patient and that of the physician. Every patient must be seen as an individual with a unique medical history and lifestyle—and to be provided with relevant care options, education, and an easy-to-navigate process. As most people with diabetes are managed by primary care physician, they must have the necessary tools  supporting them when   better tailoring  treatment plans to the needs of each individual . Understanding the patient better—and the patient understanding their condition better—is key. Finally, data and analytics are making this a reality, ensuring healthcare providers can obtain a holistic view of patients and treat them as such.

The DreaMed team is composed of professionals who are familiar with the daily struggles of diabetes care, and ensures each device is easy to use. With frequent titration changes and remote assistance, DreaMed tackles various other concerns within diabetes care, providing patients with easy access to expert care.

In all its offerings, DreaMed prioritizes privacy, security, and quality. Real-world experience and turbo-charged artificial intelligence provide optimal treatment for maintaining balanced glucose levels. The team recognizes that with thorough and consistent patient data, any physician can deliver expert level treatment.

Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.